The chaos continued when Vinay Prasad — fired last year and rehired less than two weeks later — was announced to be departing ...
Barclays 28th Annual Global Healthcare Conference March 10, 2026 9:30 AM EDTCompany ParticipantsLavina Talukdar - Senior VP & ...
Scientist Vinay Prasad, who oversees the approval process for vaccines and new therapies, is stepping down amid controversies over his decisions to tighten certain regulations. His departure for the ...
The Food and Drug Administration’s vaccine chief, Dr. Vinay Prasad, will depart the agency next month, an FDA spokesperson ...
The administration had cut crucial funding for mRNA-based therapies. The rest of the world might step in and benefit.
Dr. Vinay Prasad, a polarizing figure at the Food and Drug Administration who oversaw vaccines, is leaving the agency at the end of April, according to a Health and Human Services spokesperson. As the ...
The Bulwark on MSNOpinion
FDA reverses course, agrees to review Moderna’s flu vaccine
Andrew Egger and Jonathan Cohn give their takes on the stunning back-and-forth at the FDA over Moderna’s new mRNA flu vaccine ...
The top vaccine and biologics drug official in the U.S. Food and Drug Administration will step down in April. The agency made ...
The Food and Drug Administration's embattled vaccine chief, Dr. Vinay Prasad, is once again leaving the agency — the second ...
Incentives to bring vaccines to market are shrinking. Drugmakers are scaling back research investments and cutting jobs.
Explore how Moderna makes money through its mRNA vaccines, government contracts, and partnerships, and how products like its COVID-19 vaccine drive revenue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results